With its eyes set on remote monitoring, Israeli wearable-tech company Biobeat launched its new continuous ambulatory blood pressure monitoring (ABPM) tool late last week.
The new tool differs from typical care because it is cuffless and can capture data about a patient’s cardiac health throughout the day. Patients wear the disposable monitor on their chest. According to the company, the tech was designed to be set up by the patient at home without the need for a medical personal present.
Users are able to look at the patient’s diastolic and systolic blood pressure, heart rate, mean arterial pressure, cardiac output and systemic vascular resistance. Patients can access the information via a connected smartphone app, and doctors can tap into an online report via a web application.
WHY IT MATTERS
According to the CDC, heart disease is the leading cause of death for men, women and people of most racial and ethnic groups in the U.S. In fact, someone dies of a heart condition every 36 seconds in the country.
Increasingly the medical world is pitching remote care as a way to keep tabs on patients outside of the hospital and reduce the burden of disease management.
“As healthcare continues its digital transformation, the use of ABPM technologies has become increasingly ubiquitous across the healthcare spectrum, and will continue its growth trajectory as we venture further into the post-COVID-19 era,” Arik Ben Ishay, CEO of Biobeat, said in a statement.
“Biobeat is excited to support this positive trend with our new wearable ABPM solution, giving providers a continuous and accurate real-life view into patient cardiac health, replacing antiquated cuff-based technology.”
